SEC Form 4 · accession 0001140361-18-015078
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Officer — SVP, Corporate Controller
Period of report
Mar 22, 2018
Accepted (ET)
Mar 26, 2018 · 8:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2018 | F | 414 | $81.36 | D | 17,559 | D |
Table II — derivative securities
No Table II lines on this filing.